COMP <GO>
PRLB vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Proto Labs Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: PRLB 2
— TMO 9
■ METRIC PARITY
LAST: $77.64 (-14.60%) • MKT CAP: $1.86B
options-implied-move
—
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRLB VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRLB | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.50% | 9.30% | -5.80 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 46.3x | 30.4x | +15.90 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 3.21% | 2.40% | +0.81 | PRLB | /fcf-yield <GO> |
| Operating Margin | 4.70% | 17.40% | -12.70 | TMO | /operating-margins <GO> |
| Net Profit Margin | 4.00% | 15.10% | -11.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | — | 3.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 13.96 | 4.50 | +9.46 | PRLB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.9 | 62.9 | -35.03 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 81.3x | 36.3x | +45.00 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.86B | $262.22B | -$260.36B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRLB REV | TMO REV | PRLB GROSS % | TMO GROSS % | PRLB FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $533.1M | $44.56B | 44.5% | — | $59.7M | $6.29B |
| FY 2024 | $500.9M | $42.88B | 44.6% | — | $68.7M | $7.27B |
| FY 2023 | $0 | $42.86B | — | — | $73.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRLB // BETA —
TMO // BETA 0.94